PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Steven M Haffner Selected Research

Insulin Resistance

07/2007	Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
06/2005	Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
02/2005	Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
01/2005	A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study.
10/2004	Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
07/2004	Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
06/2004	Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
11/2003	Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
10/2003	Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
10/2003	Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
10/2003	Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
05/2003	Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
03/2003	Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study.
10/2002	Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
10/2002	Sex steroid hormones, upper body obesity, and insulin resistance.
04/2002	Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
04/2002	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

Articles by Research Topic

Disease

17	Insulin Resistance 07/2007 - 04/2002
12	Atherosclerosis (Atheroma) 07/2007 - 04/2002
11	Syndrome 01/2007 - 01/2002
4	Obesity 08/2006 - 10/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2007 - 08/2002
3	Type 2 Diabetes Mellitus (MODY) 10/2002 - 04/2002
2	Inflammation 07/2004 - 10/2003
2	Coronary Disease (Coronary Heart Disease) 07/2003 - 04/2002
1	Prediabetic State (Prediabetes) 10/2003
1	Hypertension (High Blood Pressure) 03/2003
1	Myocardial Infarction 06/2002

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 07/2007 - 04/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2005 - 04/2002
4	CholesterolIBA 01/2007 - 01/2002
3	C-Reactive ProteinIBA 08/2006 - 11/2002
3	Lipoproteins (Lipoprotein)IBA 06/2005 - 10/2002
2	ApolipoproteinsIBA 10/2004 - 11/2003
2	Plasminogen Activators (Plasminogen Activator)IBA 05/2003 - 04/2002
2	ProinsulinIBA 04/2002 - 04/2002
1	Alanine Transaminase (SGPT)IBA 07/2007
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 09/2005
1	AdiponectinIBA 07/2005
1	EnzymesIBA 07/2005
1	HDL CholesterolIBA 10/2004
1	LDL CholesterolIBA 11/2003
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2002
1	rosiglitazone (Avandia)FDA Link 08/2002
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2002